Last Update Time:
13-Mar-2025 16:00:00
ISIN:
INE0QWN01013
Sector:
Healthcare
Symbol:
ZENITHDRUG
Zenith Drugs Limited
₹56.05
₹-3.15
(-5.32%)
▼
Prev. Close
₹59.20
Open
₹59.05
Close
₹56.35
Range
₹53.25 - ₹58.85
High
₹59.20
Low
₹55.80
Ind. Close
₹0.00
VWAP
₹57.73
The current stock price of Zenith Drugs Limited is ₹56.05, with a target price range between ₹53.25 and ₹58.85. The stock has experienced a price change of ₹-3.15 (-5.32%), reflecting recent market volatility.
Today's opening price was ₹59.05, while the previous close stood at ₹59.20.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Zenith Drugs Limited Price Chart
Zenith Drugs Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 59.2
- Change: -59.20%
- Total Traded Volume: 0
- Total Buy Quantity: 10,400
- Total Sell Quantity: 9,600
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
| 55.15 | 1,600.00 | 0.00 |
| 55.20 | 800.00 | 0.00 |
| 57.00 | 800.00 | 0.00 |
| 57.05 | 800.00 | 0.00 |
| 61.95 | 0.00 | 800.00 |
| 62.00 | 0.00 | 800.00 |
| 64.20 | 0.00 | 800.00 |
| 65.65 | 0.00 | 800.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 10400
Total Sell Quantity: 9600
Shareholding Patterns of Zenith Drugs Limited
Key Trade Statistics of Zenith Drugs Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.41 |
| Traded Value (₹ Cr.) | 0.24 |
| Total Market Cap (₹ Cr.) | 96.12 |
| Free Float Market Cap (₹ Cr.) | 28.86 |
| Impact cost | N/A |
| Quantity Traded | 40,800.00 |
| Deliverable Quantity | 37,600.00 |
| % of Quantity to Traded | 92.16 |
| Security VaR | N/A |
| Index VaR | N/A |
| VaR Margin | 50 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 53.5 |
| Face Value | 10 |
Key Price Statistics of Zenith Drugs Limited
The 52-week high for Zenith Drugs Limited was ₹154.40, recorded on 26-Sep-2024. On the other hand, the 52-week low stands at ₹52.80, with the lowest value recorded on 01-Apr-2024.
The upper band for trading is ₹71.00, and the lower band is ₹47.40. The price band is 20%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (26-Sep-2024) | 154.40 |
| 52 Week Low (01-Apr-2024) | 52.80 |
| Upper Band | 71.00 |
| Lower Band | 47.40 |
| Price Band (%) | 20 |
| Daily Volatility | - |
| Annualised Volatility | - |
| Tick Size | 0.05 |
Key Securities Statistics of Zenith Drugs Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 27-Feb-2024 |
| Adjusted P/E | 10.09 |
| Symbol P/E | 9.97 |
| Index | NIFTY SME EMERGE |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Zenith Drugs Limited
| Title | Details |
|---|---|
| Board Status | SME |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Zenith Drugs Limited
| Subject | Date |
|---|---|
| General Updates | 10-Mar-2025 |
| General Updates | 04-Mar-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 29-Jan-2025 |
| Change in Auditors | 29-Jan-2025 |
| General Updates | 28-Jan-2025 |
| Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter | 13-Jan-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 13-Jan-2025 |
| Reply to Clarification- Financial results | 06-Jan-2025 |
Corporate Actions of Zenith Drugs Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | ANNUAL GENERAL MEETING | 17-Sep-2024 |
| 10 | DIVIDEND - RE 0.5 PER SHARE | 17-Sep-2024 |
Board Meetings of Zenith Drugs Limited
Financial Results of Zenith Drugs Limited
Company Directory of Zenith Drugs Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| - | Registered Address | K. No. 72/5 Village Muradpura INDORE - 453001 INDORE |
INDORE |
Insider Trading of Zenith Drugs Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
|---|---|---|---|---|---|
| No insider trading information available | |||||
Annual Reports of Zenith Drugs Limited
Investor Complaints of Zenith Drugs Limited
Event Calendar of Zenith Drugs Limited
| Purpose | Details |
|---|---|
| Board Meeting Intimation | ZENITH DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| ZENITH DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Other business. | Board Meeting Intimation |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
| ZENITH DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Other business. | Board Meeting Intimation |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
| Other business matters | To consider following matters:1. To give approval to start construction of new plant at Mohna Village, Dhar Road.2. To consider the disinvestment in My Med Private Limited, the Subsidiary Company.3. To open new bank account with HDFC Bank.4. To make an application to HDFC Bank to change the name of the company in existing credit facility from Zenith Drugs Private Limited to Zenith Drugs Limited.5. To consider increase in remuneration of Mr. Sandeep Bhardwaj (DIN: 00539347), Managing Director of the Company.6. To consider increase in remuneration of Mr. Ajay Singh Dassundi (DIN: 00835856), Director of the Company.7. To consider increase in remuneration of Mr. Bhupesh Soni (DIN: 00539355), Director of the Company.8. To conduct the postal ballot through e-voting for disinvestment in its Subsidiary and increase in remuneration of Managing Director and Executive Directors of the Company.9. To appoint Scrutinizer for conducting the Postal Ballot through e-Voting process in a fair and transparent manner.10. Any other matter with the permission of the chair if any. |
Share Transfers of Zenith Drugs Limited
Voting Results of Zenith Drugs Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 25-SEP-2024 | AGM | Adoption of Audited Financial Statementsnna.tTo consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2024, and the reports of the Board of Directors and Auditors thereon.nb.tTo consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, and the report of the Auditors thereon. |
| 25-SEP-2024 | AGM | To ratify the payment of remuneration to M/s. Nikhil Jain & Associates, Cost Accountants (Registration No. 06363). |
| 25-SEP-2024 | AGM | To approve the re-appointment of Mr. Bhupesh Soni (DIN: 00539355) as an Executive Director, liable to retire by rotation. |
| 25-SEP-2024 | AGM | To declare a final dividend of Rs. 0.5/- per equity share for the financial year ended March 31, 2024. |
| 22-MAY-2024 | Postal Ballot | To approve disinvestment in My Med Private Limited, the Subsidiary Company. |
| 22-MAY-2024 | Postal Ballot | To approve increase in remuneration of Mr. Sandeep Bhardwaj (DIN: 00539347), Managing Director of the Company. |
| 22-MAY-2024 | Postal Ballot | To approve increase in remuneration of Mr. Ajay Singh Dassundi (DIN: 00835856), Director of the Company of the Company. |
| 22-MAY-2024 | Postal Ballot | To approve increase in remuneration of Mr. Bhupesh Soni (DIN: 00539355), Director of the Company. |
FAQs on Zenith Drugs Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.